|
ZSCAN21 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.367800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.417800E-01 |
| Normal-vs-Stage2 |
8.267000E-01 |
| Normal-vs-Stage3 |
4.245700E-04 |
| Normal-vs-Stage4 |
3.315700E-02 |
| Stage1-vs-Stage2 |
6.784800E-01 |
| Stage1-vs-Stage3 |
3.458300E-03 |
| Stage1-vs-Stage4 |
9.255800E-02 |
| Stage2-vs-Stage3 |
1.366380E-01 |
| Stage2-vs-Stage4 |
1.466620E-01 |
| Stage3-vs-Stage4 |
8.533200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.527600E-01 |
| Normal-vs-AfricanAmerican |
8.812200E-01 |
| Normal-vs-Asian |
1.138600E-01 |
| Caucasian-vs-AfricanAmerican |
7.350800E-01 |
| Caucasian-vs-Asian |
2.938400E-01 |
| AfricanAmerican-vs-Asian |
3.608200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.346000E-01 |
| Normal-vs-Female |
3.106000E-01 |
| Male-vs-Female |
5.044400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.304600E-01 |
| Normal-vs-Extreme_Weight |
2.303600E-01 |
| Normal-vs-Obese |
9.738000E-01 |
| Normal-vs-Extreme_Obese |
3.173600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.020000E-01 |
| Normal_Weight-vs-Obese |
3.325800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.243600E-01 |
| Extreme_Weight-vs-Obese |
4.117600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.245000E-01 |
| Obese-vs-Extreme_Obese |
5.018400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.079600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.267600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.472200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.885200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.040800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.023000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.734400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.342000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.092200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.481400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.960000E-02 |
| Normal-VS-Type2 PRCC |
6.396400E-04 |
| Normal-VS-KIRP CIMP |
1.46140000101269E-09 |
| Normal-VS-Unclassified PRCC |
8.302000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.05749999995886E-06 |
| Type1 PRCC-VS-KIRP CIMP |
8.1494000436777E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
6.562500E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.820800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.751800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.195500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.220100E-02 |
| Normal-vs-N1 |
5.56539999999606E-05 |
| Normal-vs-N2 |
1.90209999972879E-07 |
| N0-vs-N1 |
7.566200E-02 |
| N0-vs-N2 |
7.442100E-02 |
| N1-vs-N2 |
6.618300E-02 |
|
|
